These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19622716)

  • 61. Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines.
    van Os N; Niessen LW; Bilo HJ; Casparie AF; van Hout BA
    Health Policy; 2000 Apr; 51(3):135-47. PubMed ID: 10720684
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Health and Economic Impacts of Implementing Produce Prescription Programs for Diabetes in the United States: A Microsimulation Study.
    Wang L; Lauren BN; Hager K; Zhang FF; Wong JB; Kim DD; Mozaffarian D
    J Am Heart Assoc; 2023 Aug; 12(15):e029215. PubMed ID: 37417296
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cost-effectiveness of diabetes education.
    Assal JP
    Pharmacoeconomics; 1995; 8 Suppl 1():68-71. PubMed ID: 10159008
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost-effectiveness of diabetes case management for low-income populations.
    Gilmer TP; Roze S; Valentine WJ; Emy-Albrecht K; Ray JA; Cobden D; Nicklasson L; Philis-Tsimikas A; Palmer AJ
    Health Serv Res; 2007 Oct; 42(5):1943-59. PubMed ID: 17850527
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cost-effectiveness of population-based, community, workplace and individual policies for diabetes prevention in the UK.
    Breeze PR; Thomas C; Squires H; Brennan A; Greaves C; Diggle P; Brunner E; Tabak A; Preston L; Chilcott J
    Diabet Med; 2017 Aug; 34(8):1136-1144. PubMed ID: 28294392
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A systematic review of Markov models evaluating multicomponent disease management programs in diabetes.
    Kirsch F
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):961-84. PubMed ID: 26535605
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Perspectives on self-management from the Diabetes Initiative of the Robert Wood Johnson Foundation.
    Fisher EB; Brownson CA; O'Toole ML; Anwuri VV; Shetty G
    Diabetes Educ; 2007 Jun; 33 Suppl 6():216S-224S. PubMed ID: 17620404
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Is asthma self-management cost-effective?
    Liljas B; Lahdensuo A
    Patient Educ Couns; 1997 Dec; 32(1 Suppl):S97-104. PubMed ID: 9516765
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A health economic analysis of an integrated diabetes care program in China: based on real-world evidence.
    Liang D; Zhu W; Huang J; Dong Y
    Front Public Health; 2023; 11():1211671. PubMed ID: 38169641
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study.
    Jacobs-van der Bruggen MA; Bos G; Bemelmans WJ; Hoogenveen RT; Vijgen SM; Baan CA
    Diabetes Care; 2007 Jan; 30(1):128-34. PubMed ID: 17192345
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ongoing follow-up and support for chronic disease management in the Robert Wood Johnson Foundation Diabetes Initiative.
    Fisher EB; Brownson CA; O'Toole ML; Anwuri VV
    Diabetes Educ; 2007 Jun; 33 Suppl 6():201S-207S. PubMed ID: 17620402
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost-Effectiveness of a Community-Based Diabetes Prevention Program with Participation Incentives for Medicaid Beneficiaries.
    Gilmer T; O'Connor PJ; Schiff JS; Taylor G; Vazquez-Benitez G; Garrett JE; Vue-Her H; Rinn S; Anderson J; Desai J
    Health Serv Res; 2018 Dec; 53(6):4704-4724. PubMed ID: 29770445
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cost-effectiveness of a primary care multidisciplinary Risk Assessment and Management Program for patients with diabetes mellitus (RAMP-DM) over lifetime.
    Jiao F; Wan EYF; Fung CSC; Chan AKC; McGhee SM; Kwok RLP; Lam CLK
    Endocrine; 2019 Feb; 63(2):259-269. PubMed ID: 30155847
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Cost-Effectiveness of Lifestyle Interventions for Preventing Diabetes in a Health Resource-Limited Setting.
    Ma J; Wan X; Wu B
    J Diabetes Res; 2020; 2020():7410797. PubMed ID: 32352016
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cost implications of self-management education intervention programmes in arthritis.
    Brady TJ
    Best Pract Res Clin Rheumatol; 2012 Oct; 26(5):611-25. PubMed ID: 23218426
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New drug treatments versus structured education programmes for type 2 diabetes: comparing cost-effectiveness.
    Khunti K; Chatterjee S; Carey M; Daly H; Batista-Ferrer H; Davies MJ
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):557-9. PubMed ID: 27235133
    [No Abstract]   [Full Text] [Related]  

  • 77. Economic and clinical impact of alternative disease management strategies for secondary prevention in type 2 diabetes in the Swiss setting.
    Gozzoli V; Palmer AJ; Brandt A; Spinas GA
    Swiss Med Wkly; 2001 Jun; 131(21-22):303-10. PubMed ID: 11584692
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cost-effectiveness of lifestyle modification in diabetic patients.
    Jacobs-van der Bruggen MA; van Baal PH; Hoogenveen RT; Feenstra TL; Briggs AH; Lawson K; Feskens EJ; Baan CA
    Diabetes Care; 2009 Aug; 32(8):1453-8. PubMed ID: 19435958
    [TBL] [Abstract][Full Text] [Related]  

  • 79. De Novo Cost-Effectiveness Model Framework for Nonalcoholic Steatohepatitis-Modeling Approach and Validation.
    Gal P; Feldmajer G; Augusto M; Gani R; Hook E; Bullement A; Philips Z; Smith I
    Pharmacoeconomics; 2023 Dec; 41(12):1629-1639. PubMed ID: 37505423
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Economic analysis of a diabetes-specific nutritional meal replacement for patients with type 2 diabetes.
    Randolph S; Mustad VA; Lee J; Sun J
    Asia Pac J Clin Nutr; 2010; 19(1):1-7. PubMed ID: 20199981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.